Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918620 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
A positive FH is not a prognostic factor following RT and should not alter standard treatment recommendations. Patients with two or more first degree relatives with prostate cancer had a higher likelihood of BF and DM, but there was no effect on survival. There was no interaction between a positive FH and African American race or treatment era. A positive FH was however, associated with more favorable PSA values and T-stage that may be the result of earlier screening.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hilary Bagshaw, Karen Ruth, Eric M. Horwitz, David Y.T. Chen, Mark K. Buyyounouski,